Brainstorm Cell Therapeutics shares owned by Ikarian Capital
Quarter-by-quarter ownership of Brainstorm Cell Therapeutics (BCLI) shares owned by Ikarian Capital
from 13F filings
Historical chart of Ikarian Capital investment in Brainstorm Cell Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Brainstorm Cell Therapeutics held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Brainstorm Cell Therapeutics by Ikarian Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $25k | 90k | 0.27 |
| 2023-09-30 | $18k | 90k | 0.20 |
| 2023-06-30 | $391k | 190k | 2.06 |
| 2023-03-31 | $627k | 190k | 3.30 |
| 2022-12-31 | $312k | 190k | 1.64 |
| 2022-09-30 | $839k | 190k | 4.42 |
| 2022-06-30 | $698k | 253k | 2.75 |
| 2022-03-31 | $1.0M | 304k | 3.36 |
| 2021-12-31 | $1.2M | 290k | 4.00 |
| 2021-09-30 | $955k | 290k | 3.30 |
| 2021-06-30 | $1.1M | 293k | 3.80 |
| 2021-03-31 | $1.1M | 293k | 3.83 |
| 2020-09-30 | $20M | 1.2M | 16.92 |